Cyclocarya paliurus Triterpenoids Improve Diabetes-Induced Hepatic Inflammation via the Rho-Kinase-Dependent Pathway
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cyclocarya paliurus Triterpenoids Improve Diabetes-Induced Hepatic Inflammation via the Rho-Kinase-Dependent Pathway
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-07-25
DOI
10.3389/fphar.2019.00811
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates non-alcoholic fatty liver disease via improving oxidative stress and mitochondrial dysfunction
- (2018) Meng-ge Zhao et al. BIOMEDICINE & PHARMACOTHERAPY
- Rho kinase, a potential target in the treatment of metabolic syndrome
- (2018) Vajiheh Jahani et al. BIOMEDICINE & PHARMACOTHERAPY
- IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
- (2018) N.H. Cho et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Curative effect of arjunolic acid from Terminalia arjuna in non-alcoholic fatty liver disease models
- (2018) Erenius Toppo et al. BIOMEDICINE & PHARMACOTHERAPY
- Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2017) Theo Vos et al. LANCET
- Antihyperlipidaemic effect of triterpenic acid-enriched fraction from Cyclocarya paliurus leaves in hyperlipidaemic rats
- (2017) Zhengfeng Wu et al. PHARMACEUTICAL BIOLOGY
- Enhanced Rho-kinase activity: Pathophysiological relevance in type 2 diabetes
- (2016) Lei Liu et al. CLINICA CHIMICA ACTA
- AMA0428, A Potent Rock Inhibitor, Attenuates Early and Late Experimental Diabetic Retinopathy
- (2016) Karolien Hollanders et al. CURRENT EYE RESEARCH
- Resveratrol Ameliorates the Components of Hepatic Inflammation and Apoptosis in a Rat Model of Streptozotocin-Induced Diabetes
- (2016) Mehmet Bilgehan Pektaş et al. DRUG DEVELOPMENT RESEARCH
- Sulfated modification, characterization and antioxidant activities of polysaccharide from Cyclocarya paliurus
- (2016) Jian-Hua Xie et al. FOOD HYDROCOLLOIDS
- Protein kinases: mechanisms and downstream targets in inflammation-mediated obesity and insulin resistance
- (2016) Kalyana C. Nandipati et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Metformin and salicylate synergistically activate liver AMPK, inhibit lipogenesis and improve insulin sensitivity
- (2015) Rebecca J. Ford et al. BIOCHEMICAL JOURNAL
- Rho-kinase inhibitor fasudil reduces allergic airway inflammation and mucus hypersecretion by regulating STAT6 and NFκB
- (2015) T. Xie et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Effects of esculetin on lipopolysaccharide (LPS)-induced acute lung injury via regulation of RhoA/Rho Kinase/NF-кB pathways in vivo and in vitro
- (2015) Tong Chen et al. FREE RADICAL RESEARCH
- Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease
- (2015) Johannie du Plessis et al. GASTROENTEROLOGY
- The Economic Costs of Type 2 Diabetes: A Global Systematic Review
- (2015) Till Seuring et al. PHARMACOECONOMICS
- Two triterpeniods from Cyclocarya paliurus (Batal) Iljinsk (Juglandaceae) promote glucose uptake in 3T3-L1 adipocytes: The relationship to AMPK activation
- (2015) K.N. Zhu et al. PHYTOMEDICINE
- A Brief History of Qinghaosu
- (2015) Nicholas J. White et al. TRENDS IN PARASITOLOGY
- Ursolic Acid Attenuates Diabetic Mesangial Cell Injury through the Up-Regulation of Autophagy via miRNA-21/PTEN/Akt/mTOR Suppression
- (2015) Xinxing Lu et al. PLoS One
- Cyclocarya paliurus extract modulates adipokine expression and improves insulin sensitivity by inhibition of inflammation in mice
- (2014) Cuihua Jiang et al. JOURNAL OF ETHNOPHARMACOLOGY
- Betulinic acid alleviates non-alcoholic fatty liver by inhibiting SREBP1 activity via the AMPK–mTOR–SREBP signaling pathway
- (2013) Hai Yan Quan et al. BIOCHEMICAL PHARMACOLOGY
- Rho kinase inhibition in diabetic kidney disease
- (2013) Radko Komers BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Diabetes-Induced Hepatic Pathogenic Damage, Inflammation, Oxidative Stress, and Insulin Resistance Was Exacerbated in Zinc Deficient Mouse Model
- (2012) Chi Zhang et al. PLoS One
- RhoA/Rho-kinase and vascular diseases: what is the link?
- (2010) Kenia Pedrosa Nunes et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Oxidative Stress and Diabetic Complications
- (2010) Ferdinando Giacco et al. CIRCULATION RESEARCH
- The global burden of diabetes and its complications: an emerging pandemic
- (2010) Dieren Susan van et al. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
- Mechanistic understanding of the different effects of Wuzhi Tablet (Schisandra sphenanthera extract) on the absorption and first-pass intestinal and hepatic metabolism of Tacrolimus (FK506)
- (2010) Xiao Ling Qin et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis
- (2010) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- A critical role of STAT1 in streptozotocin-induced diabetic liver injury in mice: Controlled by ATF3
- (2009) Ji Yeon Kim et al. CELLULAR SIGNALLING
- Preliminary report: Hepatic fat and inflammation in type 2 diabetes mellitus
- (2009) Aramesh Saremi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- RhoA/Rho-Kinase Contribute to the Pathogenesis of Diabetic Renal Disease
- (2008) F. Peng et al. DIABETES
- Protective role of arjunolic acid in response to streptozotocin-induced type-I diabetes via the mitochondrial dependent and independent pathways
- (2008) Prasenjit Manna et al. TOXICOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started